2013-02-27 17:59:27 -
Tierney brings more than 25 years of experience in the region to key leadership
role;
succeeds Kelvin Logan, PhD, who is retiring following 11 years with the Company
Raleigh, N.C., and Port Adelaide, South Australia, Feb. 27, 2013 - INC Research,
LLC, a therapeutically focused clinical research organization (CRO) with a
Trusted Process(®) for delivering reliable results, today announced the
promotion of Garth Tierney to Executive Vice President, Asia/Pacific responsible
for driving the strategic development and overall growth of the Company's
Asia/Pacific clinical research operations. Tierney, who served previously as the
Company's Regional General Manager, Australia and Southeast Asia, co-founded
Trident Clinical Research, an Australian-based CRO acquired by INC Research in
2011 after 14 years of operation.
"INC Research is experiencing tremendous opportunity to help drug developers
navigate the diverse and complex landscape of conducting trials across the
Asia/Pacific region, especially as many countries are poised to significantly
increase their investment in clinical research," said Tierney. "This is an
exciting time within this developing region and I look forward to helping our
customers leverage the benefits of Asia/Pacific to advance their clinical
development programs."
Prior to founding and managing Trident Clinical Research, Tierney worked for
eight years in the clinical research industry in various senior management and
operational management roles across several companies, including a global CRO,
an Australian pharmaceutical company and two global pharmaceutical companies. He
holds a graduate diploma in business administration and a Bachelor of Science in
pharmacology from the University of Adelaide and the University of New South
Wales, respectively, and worked in hypertension research for several years
before joining the pharmaceutical industry. During this time, he published
various papers and won the Whelan prize (awarded by ASCEPT).
Tierney succeeds Kelvin Logan, PhD, who will retire in April. Dr. Logan joined
INC Research in 2002 as the Company's first employee outside of North America
and played an instrumental role in growing the EMEA and Asia/Pacific regions to
2,200 staff and 43 offices, helping to catapult INC Research into one of the top
global CROs that has retained its strong global focus.
"Asia/Pacific is a key focus area for INC Research because our customers are
demanding a strong partner for on-the-ground expertise to help design and
execute custom research programs. Garth is the obvious choice to take over the
helm in the region based on his extensive knowledge and operational prowess,"
said COO Alistair Macdonald. "Additionally, I'd like to personally thank Kelvin
for all of his tremendous accomplishments in building the Company's Asia/Pacific
operations into what they are today."
INC Research provides Phase I to IV clinical development services in the
Asia/Pacific region with extensive coverage across China, India, Australia,
Singapore, Philippines, South Korea, Taiwan, Hong Kong, Malaysia, Thailand and
New Zealand. The Company has the broad regional presence, therapeutic expertise,
operational excellence and ability to apply international insights to local
projects to meet the needs of drug developers. For more information, visit the
website for more information on INC Research's clinical trial services and
experience in the region.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical developmentprograms
of the highest integrity. Pharmaceutical and biotechnology companies look to INC
Research for a complete range of customized Phase I through Phase IV programs in
all therapeutic areas and innovative pediatric and women's health trials. The
Company's Trusted Process(®) methodology and therapeutic foresight lead
customers to more confident, better-informed drug and device development
decisions. INC Research is headquartered in Raleigh, NC. For more information,
please visit www.incresearch.com or follow us at @inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1681710]
